β‐TrCP overexpression enhances cisplatin sensitivity by depleting BRCA1
Cisplatin is one of the most used anticancer chemotherapy agents; however, over time, patients develop resistance to the treatment, and survival rates drop dramatically. Investigation of tumor cell resistance mechanisms could increase sensitivity and prevent cancer progression. Here, we investigated...
Guardat en:
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wiley
2026-02-01
|
| Col·lecció: | Molecular Oncology |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1002/1878-0261.70089 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|